Class I T-cell epitope prediction: improvements using a combination of proteasome cleavage, TAP affinity, and MHC binding.

Cleavage by the proteasome is responsible for generating the C terminus of T-cell epitopes. Modeling the process of proteasome cleavage as part of a multi-step algorithm for T-cell epitope prediction will reduce the number of non-binders and increase the overall accuracy of the predictive algorithm. Quantitative matrix-based models for prediction of the proteasome cleavage sites in a protein were developed using a training set of 489 naturally processed T-cell epitopes (nonamer peptides) associated with HLA-A and HLA-B molecules. The models were validated using an external test set of 227 T-cell epitopes. The performance of the models was good, identifying 76% of the C-termini correctly. The best model of proteasome cleavage was incorporated as the first step in a three-step algorithm for T-cell epitope prediction, where subsequent steps predicted TAP affinity and MHC binding using previously derived models.

[1]  A. Krensky,et al.  Identification of epitopes of Mycobacterium tuberculosis 16-kDa protein recognized by human leukocyte antigen-A*0201 CD8(+) T lymphocytes. , 2002, The Journal of infectious diseases.

[2]  Akira Hattori,et al.  An IFN-γ–induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I–presented peptides , 2002, Nature Immunology.

[3]  Irini A. Doytchinova,et al.  JenPep: a database of quantitative functional peptide data for immunology , 2002, Bioinform..

[4]  Irini Doytchinova,et al.  The HLA-A2-supermotif: a QSAR definition. , 2003, Organic & biomolecular chemistry.

[5]  J. Drijfhout,et al.  Identification of Major Epitopes of Mycobacterium tuberculosis AG85B That Are Recognized by HLA-A*0201-Restricted CD8+ T Cells in HLA-Transgenic Mice and Humans1 , 2000, The Journal of Immunology.

[6]  S. Brunak,et al.  Prediction of proteasome cleavage motifs by neural networks. , 2002, Protein engineering.

[7]  A. Goldberg,et al.  Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides. , 1999, Journal of immunology.

[8]  R. Boggia,et al.  Genetic algorithms as a strategy for feature selection , 1992 .

[9]  K. Parker,et al.  Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. , 1994, Journal of immunology.

[10]  John Sidney,et al.  Identification of Novel HLA-A2-Restricted Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Epitopes Predicted by the HLA-A2 Supertype Peptide-Binding Motif , 2001, Journal of Virology.

[11]  M. Orłowski,et al.  Pituitary multicatalytic proteinase complex. Specificity of components and aspects of proteolytic activity. , 1989, Biochemistry.

[12]  Channa K. Hattotuwagama,et al.  New horizons in mouse immunoinformatics: reliable in silico prediction of mouse class I histocompatibility major complex peptide binding affinity. , 2004, Organic & biomolecular chemistry.

[13]  H. Rammensee,et al.  SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.

[14]  T. Eberlein,et al.  Mammaglobin-A is a tumor-associated antigen in human breast carcinoma. , 2003, Surgery.

[15]  Pingping Guan,et al.  HLA-A3 supermotif defined by quantitative structure-activity relationship analysis. , 2003, Protein engineering.

[16]  B. J. Van den Eynde,et al.  Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome. , 2001, Current opinion in immunology.

[17]  J. Shabanowitz,et al.  Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol. , 1998, Journal of immunology.

[18]  H. Whittle,et al.  Vigorous but Short-Term Gamma Interferon T-Cell Responses against a Dominant HLA-A*02-Restricted Measles Virus Epitope in Patients with Measles , 2003, Journal of Virology.

[19]  M. Groettrup,et al.  Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer. , 2000, Cancer research.

[20]  K Eichmann,et al.  The proteolytic fragments generated by vertebrate proteasomes: structural relationships to major histocompatibility complex class I binding peptides. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Shabanowitz,et al.  Differences in the Expression of Human Class I MHC Alleles and Their Associated Peptides in the Presence of Proteasome Inhibitors1 , 2001, The Journal of Immunology.

[22]  S. Stevanović,et al.  Combining computer algorithms with experimental approaches permits the rapid and accurate identification of T cell epitopes from defined antigens. , 2001, Journal of immunological methods.

[23]  Han van de Waterbeemd,et al.  Chemometric methods in molecular design , 1995 .

[24]  Andrew P. Bradley,et al.  The use of the area under the ROC curve in the evaluation of machine learning algorithms , 1997, Pattern Recognit..

[25]  H. Margalit,et al.  Sequence signals for generation of antigenic peptides by the proteasome: implications for proteasomal cleavage mechanism. , 2000, Journal of molecular biology.

[26]  Vladimir Brusic,et al.  Virtual models of the HLA class I antigen processing pathway. , 2004, Methods.

[27]  Wendy J M van Zuylen,et al.  Potent T cell response to a class I‐binding 13‐mer viral epitope and the influence of HLA micropolymorphism in controlling epitope length , 2004, European journal of immunology.

[28]  M Orlowski,et al.  Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. , 1993, Biochemistry.

[29]  Irini A. Doytchinova,et al.  Towards the in silico identification of class II restricted T-cell epitopes: a partial least squares iterative self-consistent algorithm for affinity prediction , 2003, Bioinform..

[30]  N. Shastri,et al.  Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. , 2002, Annual review of immunology.

[31]  C. Marañón,et al.  The immunization of A2/K(b) transgenic mice with the KMP11-HSP70 fusion protein induces CTL response against human cells expressing the T. cruzi KMP11 antigen: identification of A2-restricted epitopes. , 2001, Molecular immunology.

[32]  Irini A. Doytchinova,et al.  JenPep: A Novel Computational Information Resource for Immunobiology and Vaccinology , 2003, J. Chem. Inf. Comput. Sci..

[33]  A. Rivett,et al.  Use of serine-protease inhibitors as probes for the different proteolytic activities of the rat liver multicatalytic proteinase complex. , 1992, European journal of biochemistry.

[34]  E. Rosenberg,et al.  Vpr Is Preferentially Targeted by CTL During HIV-1 Infection1 , 2001, The Journal of Immunology.

[35]  Darren R Flower,et al.  Coupling In Silico and In Vitro Analysis of Peptide-MHC Binding: A Bioinformatic Approach Enabling Prediction of Superbinding Peptides and Anchorless Epitopes , 2004, The Journal of Immunology.

[36]  A. Ferrara,et al.  Identification of a naturally processed HLA‐A*0201 HPV18 E7 T cell epitope by tumor cell mediated in vitro vaccination , 2003, International journal of cancer.

[37]  N. Shastri,et al.  Specific proteolytic cleavages limit the diversity of the pool of peptides available to MHC class I molecules in living cells. , 1999, Journal of immunology.

[38]  M. Rudolf,et al.  Human T-cell responses to HLA-A-restricted high binding affinity peptides of human papillomavirus type 18 proteins E6 and E7. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[39]  V Brusic,et al.  Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules. , 1998, Journal of immunology.

[40]  A. Goldberg,et al.  Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Yewdell,et al.  The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: involvement of nonproteasomal cytosolic proteases in antigen processing? , 1997, Journal of immunology.

[42]  P. Romero,et al.  HLA‐A*0201 restricted CD8+ T‐lymphocyte responses to malaria: identification of new Plasmodium falciparum epitopes by IFN‐γ ELISPOT , 2000, Parasite immunology.

[43]  John Cruz,et al.  Quantitation of CD8+ T Cell Responses to Newly Identified HLA-A*0201–restricted T Cell Epitopes Conserved Among Vaccinia and Variola (Smallpox) Viruses , 2003, The Journal of experimental medicine.

[44]  Hans-Georg Rammensee,et al.  MHC ligands and peptide motifs: first listing , 2004, Immunogenetics.

[45]  P. Kloetzel,et al.  Modeling the MHC class I pathway by combining predictions of proteasomal cleavage,TAP transport and MHC class I binding , 2005, Cellular and Molecular Life Sciences CMLS.

[46]  M. Probst-Kepper,et al.  Conformational Restraints and Flexibility of 14-Meric Peptides in Complex with HLA-B*35011 , 2004, The Journal of Immunology.

[47]  H. Rammensee,et al.  Discrete Cleavage Motifs of Constitutive and Immunoproteasomes Revealed by Quantitative Analysis of Cleavage Products , 2001, The Journal of experimental medicine.

[48]  W Keilholz,et al.  Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[49]  K. Hadeler,et al.  PAProC: a prediction algorithm for proteasomal cleavages available on the WWW , 2001, Immunogenetics.

[50]  M. Kasahara,et al.  The MHC class I ligand‐generating system: roles of immunoproteasomes and the interferon‐4gMY‐inducible proteasome activator PA28 , 1998, Immunological reviews.

[51]  L. Cooper,et al.  Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma. , 2003, Blood.

[52]  D. Flower,et al.  Additive method for the prediction of protein-peptide binding affinity. Application to the MHC class I molecule HLA-A*0201. , 2002, Journal of proteome research.

[53]  Channa K. Hattotuwagama,et al.  AntiJen: a quantitative immunology database integrating functional, thermodynamic, kinetic, biophysical, and cellular data , 2005, Immunome research.

[54]  W. Baumeister,et al.  A giant protease with potential to substitute for some functions of the proteasome. , 1999, Science.

[55]  R. Tisch,et al.  Class I Major Histocompatibility Complex Anchor Substitutions Alter the Conformation of T Cell Receptor Contacts* , 2001, The Journal of Biological Chemistry.

[56]  Hans-Georg Rammensee,et al.  Two new proteases in the MHC class I processing pathway , 2000, Nature Immunology.

[57]  S. Brunak,et al.  Predicting proteasomal cleavage sites: a comparison of available methods. , 2003, International immunology.

[58]  E. Appella,et al.  T Cell Activity Correlates with Oligomeric Peptide-Major Histocompatibility Complex Binding on T Cell Surface* , 2001, The Journal of Biological Chemistry.

[59]  A. Goldberg,et al.  Interferon-γ Can Stimulate Post-proteasomal Trimming of the N Terminus of an Antigenic Peptide by Inducing Leucine Aminopeptidase* , 1998, The Journal of Biological Chemistry.

[60]  C. Bony,et al.  Identification in humans of HPV‐16 E6 and E7 protein epitopes recognized by cytolytic T lymphocytes in association with HLA‐B18 and determination of the HLA‐B18‐specific binding motif , 2000, European journal of immunology.

[61]  P. Cresswell,et al.  Cellular mechanisms governing cross-presentation of exogenous antigens , 2004, Nature Immunology.

[62]  N. Shastri,et al.  ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum , 2002, Nature.

[63]  A. Goldberg,et al.  The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8–9 residues , 2002, Nature Immunology.

[64]  A. Goldberg,et al.  26S proteasomes and immunoproteasomes produce mainly N‐extended versions of an antigenic peptide , 2001, The EMBO journal.

[65]  Darren R Flower,et al.  Towards in silico prediction of immunogenic epitopes. , 2003, Trends in immunology.

[66]  P. Kloetzel,et al.  A theoretical approach towards the identification of cleavage-determining amino acid motifs of the 20 S proteasome. , 1999, Journal of molecular biology.

[67]  Christina Kuttler.  An Algorithm for the Prediction of Proteasomal Cleavages , 2000, German Conference on Bioinformatics.

[68]  Steven A. Rosenberg,et al.  Induction of Tumor-Reactive Cytotoxic T-Lymphocytes Using a Peptide from NY-ESO-1 Modified at the Carboxy-terminus to Enhance HLA-A2.1 Binding Affinity and Stability in Solution , 2001, Journal of immunotherapy.

[69]  Pingping Guan,et al.  MHCPred: a server for quantitative prediction of peptide-MHC binding , 2003, Nucleic Acids Res..

[70]  A. Goldberg,et al.  The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides. , 2002, Molecular immunology.

[71]  P. Kloetzel,et al.  A kinetic model of vertebrate 20S proteasome accounting for the generation of major proteolytic fragments from oligomeric peptide substrates. , 2000, Biophysical journal.

[72]  Hans-Georg Rammensee,et al.  Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[73]  G. Pantaleo,et al.  Induction of a cytotoxic T-cell response to HIV-1 proteins with short synthetic peptides and human compatible adjuvants. , 2001, Vaccine.

[74]  Shelley L. Hemsley,et al.  Transporter Associated with Antigen Processing Preselection of Peptides Binding to the MHC: A Bioinformatic Evaluation , 2004, The Journal of Immunology.

[75]  Vladimir Brusic,et al.  A neural network model approach to the study of human TAP transporter , 1998, Silico Biol..